| XLS |
|
|
|
|
||
|
€ million |
Jan.–Sept. 2014 |
Jan.–Sept. 2013 |
||
|
||||
|
Profit after tax |
883.0 |
927.6 |
||
|
Depreciation/amortization/impairment losses/reversals of impairments |
980.5 |
996.8 |
||
|
Changes in inventories |
17.8 |
–117.1 |
||
|
Changes in trade accounts receivable |
–78.3 |
–31.9 |
||
|
Changes in trade accounts payable |
–98.5 |
77.3 |
||
|
Changes in provisions |
0.2 |
35.3 |
||
|
Changes in other assets and liabilities |
–132.6 |
–55.5 |
||
|
Neutralization of gain/loss on disposals of assets |
–12.2 |
–50.0 |
||
|
Other non-cash income and expenses |
4.4 |
2.6 |
||
|
Net cash flows from operating activities |
1,564.2 |
1,785.1 |
||
|
|
|
|
||
|
Payments for investments in intangible assets |
–74.1 |
–66.3 |
||
|
Payments from the disposal of intangible assets1 |
0.6 |
0.8 |
||
|
Payments for investments in property, plant and equipment |
–269.9 |
–235.3 |
||
|
Payments from the sale of property, plant and equipment1 |
6.3 |
266.2 |
||
|
Payments for investments in financial assets1 |
–1,852.2 |
–899.7 |
||
|
Payments for the obtainment of control over AZ Electronic Materials S.A. less acquired cash and cash equivalents |
–1,419.4 |
– |
||
|
Payments for other acquisitions |
– |
–15.1 |
||
|
Payments from the disposal of other financial assets1 |
3,090.2 |
337.8 |
||
|
Payments from the divestment of the Discovery and Development Solutions business field |
20.9 |
– |
||
|
Net cash flows from investing activities |
–497.5 |
–611.7 |
||
|
|
|
|
||
|
Dividend payments to Merck KGaA shareholders1 |
–122.8 |
–109.9 |
||
|
Dividend payments to non-controlling interests1 |
–3.0 |
–3.3 |
||
|
Withdrawals from retained earnings by E. Merck KG1 |
–382.7 |
–304.5 |
||
|
Payments from new borrowings of financial liabilities from E. Merck1 |
213.6 |
196.9 |
||
|
Payments for the acquisition of shares in AZ Electronic Materials S.A. after obtainment of control |
–351.4 |
– |
||
|
Repayment of bonds |
– |
–750.0 |
||
|
Changes in other current and non-current financial liabilities |
–111.7 |
4.3 |
||
|
Net cash flows from financing activities |
–758.1 |
–966.4 |
||
|
|
|
|
||
|
Changes in cash and cash equivalents |
308.7 |
207.0 |
||
|
Changes in cash and cash equivalents due to currency translation |
48.8 |
–21.4 |
||
|
Cash and cash equivalents as of January 1 |
980.8 |
729.7 |
||
|
Cash and cash equivalents as of September 30 |
1,338.3 |
915.3 |
||
|
Plus cash and cash equivalents included in assets held for sale |
– |
– |
||
|
Cash and cash equivalents as of September 30 |
1,338.3 |
915.3 |
||